Conference Coverage

Eplerenone Effective Across All High-Risk Heart Failure Patients


 

FROM THE ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY

Pfizer sponsored the trial. Dr. Pitt reports financial relationships with several firms excluding Pfizer. His coauthors report similar relationships including employment with Pfizer.

Pages

Recommended Reading

Emphasize Soy, Nut, Viscous Fiber Consumption to Cut LDL Cholesterol
MDedge Family Medicine
Psoriasis, Biologics: Concern Remains About CV Risks
MDedge Family Medicine
Diastolic Dysfunction Prevalence Rises as Patients Age
MDedge Family Medicine
Chronic Disease: Hospitalization May Cause Medication Stoppage
MDedge Family Medicine
FDA: High-Dose Citalopram Tied to Heart Risks
MDedge Family Medicine
Cardiopreventive Drug Use Low Worldwide
MDedge Family Medicine
Triglycerides Predict Heart Risk When Glucose Tolerance Is Normal
MDedge Family Medicine
Dalcetrapib Boosts HDL Without Bumping BP
MDedge Family Medicine
Apixaban Beat Warfarin Regardless of Warfarin-Treatment Quality
MDedge Family Medicine
Apixaban Scores on Efficacy and Safety Over Warfarin in AF
MDedge Family Medicine